Molecular Design and Synthesis of New 3,4-Dihydropyrimidin-2(1H)-Ones as Potential Anticancer Agents with VEGFR-2 Inhibiting Activity.
Anticancer Agents Med Chem
; 19(3): 310-322, 2019.
Article
in En
| MEDLINE
| ID: mdl-30019649
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidinones
/
Drug Design
/
Vascular Endothelial Growth Factor Receptor-2
/
Protein Kinase Inhibitors
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Anticancer Agents Med Chem
Journal subject:
ANTINEOPLASICOS
/
QUIMICA
Year:
2019
Document type:
Article
Affiliation country:
Egypt